Search Results - Andrew Harper
- Showing 1 - 4 results of 4
-
1
-
2
-
3
-
4
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase by Susan Branford, Zbigniew Rudzki, Andrew Harper, Andrew Grigg, K Taylor, Simon Durrant, Chris Arthur, Peter Browett, Anthony P. Schwarer, Dávid Ma, John F. Seymour, Kenneth F. Bradstock, David Joske, Kevin Lynch, Insa Gathmann, Timothy P. Hughes
Published 2003Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Cancer
Demography
Incidence (geometry)
Optics
Physics
Sociology
Cervical cancer
Confidence interval
Environmental health
Population
Alpha interferon
Biochemistry
Biology
Breast cancer
Cancer registry
Chromosomal translocation
Cohort
Cohort study
Colorectal cancer
Cytarabine
Discontinuation
Epidemiology
Gastroenterology
Gene
Gerontology
Gynecology
Imatinib
Imatinib mesylate